Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Medtronic
Julphar
Harvard Business School
Express Scripts
Fish and Richardson
Cerilliant
Argus Health
Chinese Patent Office
Mallinckrodt

Generated: August 17, 2017

DrugPatentWatch Database Preview

Theophylline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for theophylline and what is the scope of theophylline patent protection?

Theophylline
is the generic ingredient in fifty-two branded drugs marketed by Nostrum Pharms Llc, Alpharma Us Pharms, Forest Labs, Sanofi Aventis Us, Cenci, Ortho Mcneil Pharm, 3M, Pliva, Schering, Hospira Inc, B Braun, Ferndale Labs, Pharm Assoc, Warner Chilcott, Taro, Alembic Pharms Ltd, Scherer Rp, Hospira, Auxilium Pharms Inc, Inwood Labs, Teva Pharms, Roxane, Able, Fleming Pharms, Actient Pharms, Auxilium Pharms Llc, Wockhardt, Baxter Hlthcare, Chartwell Rx, Pharm Res Assoc, Cent Pharms, Whitby, Fisons, Glenmark Generics, Silarx, Monarch Pharms, Panray, Mylan Ireland Ltd, Sandoz, Graham Dm, Kv Pharm, Precision Dose, Roerig, Schwarz Pharma, Halsey, Rhodes Pharms, Lannett, Nostrum Labs Inc, Tris Pharma Inc, Medicis, and Novartis, and is included in one hundred and nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline. Thirty suppliers are listed for this compound.

Summary for Generic Name: theophylline

Tradenames:52
Patents:0
Applicants:51
NDAs:119
Drug Master File Entries: see list36
Suppliers / Packagers: see list30
Bulk Api Vendors: see list84
Clinical Trials: see list75
Patent Applications: see list9,113
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:theophylline at DailyMed

Pharmacology for Ingredient: theophylline

Ingredient-typeXanthines
Drug ClassMethylxanthine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
THEOPHYLLINE
theophylline
TABLET, EXTENDED RELEASE;ORAL089763-001Apr 30, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
Cent Pharms
THEOPHYLLINE
theophylline
CAPSULE, EXTENDED RELEASE;ORAL088689-001Feb 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Fleming Pharms
AEROLATE JR
theophylline
CAPSULE, EXTENDED RELEASE;ORAL085075-002Nov 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
SLO-PHYLLIN
theophylline
TABLET;ORAL085204-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fleming Pharms
AEROLATE SR
theophylline
CAPSULE, EXTENDED RELEASE;ORAL085075-001Nov 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: theophylline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms
QUIBRON-T/SR
theophylline
TABLET, EXTENDED RELEASE;ORAL087563-001Jun 21, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Colorcon
AstraZeneca
Fuji
US Department of Justice
Deloitte
Daiichi Sankyo
Cipla
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot